ALPS Medical Breakthroughs ETF

SBIO
$63.25 (+ $1.88 + 3.06%)
Last updated: 2026-06-29 03:52 UTC
SBIO Metrics
Exchange
🇺🇸 NYSE ARCX
NYSE ArcaUnited StatesAmerica/New_York
SectorHealth
IndustryALPS
ISINUS00162Q5936
CUSIP00162Q593
Market Price63.25
Dividend Yield 2.0%
Dividend Growth
1YN/A
3YN/A
5YN/A
10YN/A
Annual Dividend 1.0
Latest Payout ($)N/A
Latest Payout DateN/A
Dividend FrequencyYearly
P/E RatioN/A
EPSN/A
Market CapN/A
Book ValueN/A
Price to BookN/A
BetaN/A
52w High52.9
52w Low22.33
Next Earnings DateN/A

ALPS Medical Breakthroughs ETF trades under ticker SBIO on NYSE as an ETF. Use this page to review its stock price, dividends, and price history. The page also shows Health exposure. Identifiers: ISIN US00162Q5936, CUSIP 00162Q593.

About the Company
The fund employs a "passive management" - or indexing - investment approach designed to track the performance of the underlying index. It will normally invest at least 80% of its net assets in securities that comprise the underlying index. The underlying index is comprised of small and mid-cap stocks of biotechnology companies that have one or more drugs in either Phase II or Phase III of the U.S. Food and Drug Administration clinical trials.
Price History